← Back to Search

Robotic Surgery

Robotic Surgery for Head and Neck Cancer

N/A

Recruiting

Led By Eric J Moore

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient must present with indications for diagnostic or therapeutic surgery for benign or malignant diseases of the head and neck

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measures assessed at time of intervention (during surgery)

Awards & highlights

Study Summary

This trial will test if a new, minimally-invasive surgery to remove throat tumors can be done more quickly and effectively than traditional surgery.

Who is the study for?

This trial is for individuals who need surgery for benign or malignant head and neck conditions, specifically in the throat area. Participants must be able to give written consent. It's not specified who can't join because the exclusion criteria are missing.Check my eligibility

What is being tested?

The study tests if using Transoral Robotic Surgery (TORS) with patients seated improves visualization and speeds up removal of throat tumors, compared to traditional methods.See study design

What are the potential side effects?

Potential side effects may include typical surgical risks such as bleeding, infection, pain at the surgery site, swelling, and complications related to robotic equipment use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need surgery for a disease in my head or neck, whether it's cancerous or not.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measures assessed at time of intervention (during surgery)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measures assessed at time of intervention (during surgery)

This trial's timeline: 3 weeks for screening, Varies for treatment, and measures assessed at time of intervention (during surgery) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

TORS surgery completion in the seated position

Secondary outcome measures

Estimated amount of blood loss during participants' surgery

Length of participants' surgical time

Trial Design

1Treatment groups

Experimental Treatment

Group I: Trans Oral Robotic Surgery (TORS)Experimental Treatment1 Intervention

Patient's are having TORS surgery in a seated position

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,209 Previous Clinical Trials

3,767,084 Total Patients Enrolled

Eric J MoorePrincipal InvestigatorMayo Clinic

1 Previous Clinical Trials

10 Total Patients Enrolled

Kathryn Van Abel, MDPrincipal InvestigatorMayo Clinic

1 Previous Clinical Trials

100 Total Patients Enrolled

Media Library

Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device (Robotic Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT02792322 — N/A

Head and Neck Cancers Research Study Groups: Trans Oral Robotic Surgery (TORS)

Head and Neck Cancers Clinical Trial 2023: Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device Highlights & Side Effects. Trial Name: NCT02792322 — N/A

Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device (Robotic Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02792322 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently any opportunities to join this research project?

"Clinicaltrials.gov sources indicate that this clinical trial is currently searching for participants. This research was initially made public on May 1st 2016 and the latest update was published in September of 2022."

Answered by AI

What is the estimated participant count for this scientific investigation?

"Affirmative. Per the clinicaltrials.gov page, this trial is actively seeking participants with an initial post date of May 1st 2016 and a recent edit on September 12th 2022. The study aims to recruit 50 individuals from one medical centre."

Answered by AI

Are there any eligibility criteria for participating in this clinical trial?

"This clinical study, which is open to patients aged 18 through 90 with oropharnyx cancer, will be enrolling 50 individuals. In order to qualify for the trial, potential participants must have a pre-operative diagnosis or therapeutic surgery of head and neck malignant/benign diseases and provide written consent."

Answered by AI